Jane Street Group, LLC Mirati Therapeutics, Inc. Put Options Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	BUY	$75.82 - $150.97 $1.55 Million - $3.09 Million	20,500 Added 38.83%	73,300 $6.03 Million
Q4 2021 Feb 15, 2022	BUY	$132.01 - $190.29 $1.94 Million - $2.8 Million	14,700 Added 38.58%	52,800 $7.75 Million
Q3 2021 Nov 16, 2021	BUY	$132.13 - $177.45 $2.79 Million - $3.74 Million	21,100 Added 124.12%	38,100 $6.74 Million
Q2 2021 Aug 16, 2021	BUY	$144.0 - $179.73 $57,600 - $71,892	400 Added 2.41%	17,000 $2.75 Million
Q1 2021 May 18, 2021	BUY	$158.92 - $221.61 $95,351 - $132,966	600 Added 3.75%	16,600 $2.84 Million
Q4 2020 Feb 17, 2021	BUY	$162.05 - $240.27 $324,100 - $480,540	2,000 Added 14.29%	16,000 $3.51 Million
Q3 2020 Nov 17, 2020	BUY	$113.26 - $167.27 $838,124 - $1.24 Million	7,400 Added 112.12%	14,000 $2.33 Million
Q2 2020 Aug 17, 2020	BUY	$72.01 - $120.39 $475,266 - $794,574	6,600 New	6,600 $754,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.